Log In
BCIQ
Print this Print this
 

NVP019

  Manage Alerts
Collapse Summary General Information
Company NeuroVive Pharmaceutical AB
DescriptionNext generation non-cyclosporin cyclophillin inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Renal (unspecified)
Indication DetailsKidney protection in cardiac surgery
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today